S&P 500 Consumer Staples Sector SEC Filings — October 29, 2026

USA S&P 500 Consumer Staples

By Gunpowder Editorial ·

7 high priority 4 medium priority 11 total filings analysed

Executive Summary

The 11 filings from S&P 500 Consumer Staples companies reveal a sector navigating a tug-of-war between price-driven revenue growth and volume declines, with mixed sentiment dominating (6 of 11 filings). Portfolio-level revenue growth averaged ~2.3% YoY, but organic growth was weaker (Hershey +0.8%, Mondelez +2.1%), as volume/mix turned negative at Hershey (-10 points) and flat at Mondelez North America.

Margin trends diverged sharply: Hershey's gross margin expanded ~1,350 bps to 46.1% on lower costs and tariff refunds, while Mondelez's SG&A jumped 13.3% YTD, and Altria's operating income growth was flattered by a prior-year impairment. Insider activity was sparse, but capital allocation remained shareholder-friendly: Altria expanded its buyback by $1B, Hershey repurchased $439M in stock and paid $859M in dividends, and Kimberly-Clark priced $4.9B in notes to fund its Kenvue acquisition. Management changes at Clorox (new CEO from Unilever) and Hormel (CEO role expanded) signal strategic shifts, while Church & Dwight added a director with deep consumer goods experience. The most critical developments are Hershey's raised EPS guidance (36-38.5% growth) despite volume weakness, Mondelez's tuck-in acquisition of Undercover Snacks, and Kimberly-Clark's debt-funded Kenvue deal, which will reshape the household products landscape. Overall, the sector faces persistent volume pressure and cost inflation, but strong pricing power, cost controls, and capital returns are supporting earnings.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K · DEFA14A · 10-Q

Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from October 22, 2026.

Investment Signals (12)

  • Hershey ↓ (BULLISH)
    ▲

    Adjusted EPS guidance raised to 36-38.5% growth (from 32.5-35%), Q3 adjusted EPS $2.64 (+103.1% YoY), gross margin expanded to 46.1% from 32.6%, driven by lower cost of sales and tariff refunds ($0.22 benefit)

  • Altria ↓ (BULLISH)
    ▲

    Raised 2026 adjusted EPS guidance to $5.66-$5.74 (4.5-6.0% growth) and authorized $1B buyback expansion; Q3 adjusted EPS $1.52 (+4.8% YoY) on 1.0% revenue growth, with nine-month operating cash flow supporting returns

  • Mondelez ↓ (BULLISH)
    ▲

    Q3 net earnings surged 75.6% to $1,305M, diluted EPS $1.02 (+78.9% YoY), gross profit up 50.2% on cost of sales decline; announced acquisition of Undercover Snacks and reaffirmed 2026 organic growth of at least 2%

  • ▲

    Priced $4.9B in senior notes across five tranches to fund Kenvue acquisition, expected to close Q4 2026; deal will create a consumer health powerhouse and likely drive synergies

  • Clorox ↓ (BULLISH)
    ▲

    Appointed Fabian Garcia (Unilever Personal Care president) as CEO effective Jan 5, 2027, bringing deep consumer goods expertise; $11M sign-on RSU aligns interests, potential for strategic refresh

  • ▲

    CEO John Ghingo's employment agreement terminated early as he assumes CEO role with no specified term, signaling board confidence and continuity; no financial impact disclosed

  • ▲

    Elected Jonathon Nudi (Masco CEO, ex-General Mills group president) to board, adding significant consumer packaged goods and international experience; effective Jan 1, 2027

  • Hershey ↓ (BULLISH)
    ▲

    Q3 net sales $3,275.5M (+3.0% YoY), operating profit surged 88.2% to $817.7M, net income more than doubled to $580.8M; nine-month operating cash flow $1,638.8M

  • Altria ↓ (NEUTRAL)
    ▲

    Q3 net revenues $6,132M (+1.0% YoY), net earnings $2,518M (+6.0% YoY), diluted EPS $1.51 vs $1.41; domestic cigarette volume decline moderated to -2.9%

  • Mondelez ↓ (NEUTRAL)
    ▲

    Q3 organic growth +2.1% driven by volume/mix +1.8% and pricing +0.3%; developed markets growth +0.5% (organic +0.8%)

  • Clorox ↓ (NEUTRAL)
    ▲

    Q1 fiscal 2027 results scheduled for Nov 2, 2026; watch for initial guidance under new CEO and potential strategic updates

  • Hershey ↓ (BEARISH)
    ▲

    Volume declined ~10 points overall and ~14% in International, reflecting elasticity and shipment timing; accounts receivable rose 52.6% to $1,113.4M, absorbing $385.7M of operating cash

Risk Flags (10)

  • Hershey↓ [HIGH RISK]
    ▼

    Volume declined ~10 points overall and ~14% in International, with management citing price elasticity and shipment timing; organic growth only +0.8% despite 11 points of net price realization, indicating underlying demand weakness

  • Altria↓ [HIGH RISK]
    ▼

    Marlboro retail share declined 1.0 point YoY to 39.5%, and domestic cigarette volume fell 2.9%; discount brands grew 40.5%, signaling mix shift toward lower-priced products that pressures margins

  • Mondelez↓ [HIGH RISK]
    ▼

    Europe net revenues declined 3.3% (-2.1% organic) and YTD organic decline of -2.0%; North America volume/mix flat at 0.0 pp, growth entirely price-driven; YTD adjusted EPS declined 0.9%

  • Mondelez↓ [MEDIUM RISK]
    ▼

    SG&A expenses rose 12.1% in Q3 to $2,012M and 13.3% YTD to $5,929M; asset impairments and exit costs climbed to $128M in Q3 from $41M, indicating cost pressures and portfolio restructuring

  • Altria↓ [MEDIUM RISK]
    ▼

    Cash and cash equivalents fell 39.7% to $2,697M from $4,474M at year-end 2025; stockholders' equity remains in deficit at $(2,173)M, though improved from $(3,452)M

  • Hershey↓ [MEDIUM RISK]
    ▼

    Accounts receivable rose 52.6% to $1,113.4M from $729.5M at year-end 2025, absorbing $385.7M of operating cash; cash down 26.9% YTD to $676.7M despite strong earnings, raising working capital concerns

  • Altria↓ [MEDIUM RISK]
    ▼

    NJOY ACE not expected to return to U.S. marketplace in 2026, and e-vapor industry growth is moderating; limits growth optionality in reduced-risk products

  • Clorox↓ [MEDIUM RISK]
    ▼

    CEO transition effective Jan 5, 2027, with outgoing CEO Linda Rendle stepping down for health reasons; execution risk during leadership change and potential strategic disruption

  • Kimberly-Clark↓ [MEDIUM RISK]
    ▼

    $4.9B debt issuance to fund Kenvue acquisition increases leverage; integration risk and potential dilution if synergies not realized; exchange offers for Kenvue notes ongoing

  • Hershey↓ [MEDIUM RISK]
    ▼

    Q3 2026 adjusted EPS includes $0.22 from tariff refunds; 2026 guidance includes $0.03 from Q2, meaning ~$0.25 of EPS is non-recurring, overstating underlying earnings power

Opportunities (10)

  • Hershey↓ (OPPORTUNITY)
    ◆

    Raised EPS guidance and strong gross margin expansion (46.1% vs 32.6%) despite volume weakness; if volume stabilizes, earnings could outperform; watch for volume recovery in Q4 2026 and 2027

  • Altria↓ (OPPORTUNITY)
    ◆

    $1B buyback expansion and 4.5-6.0% EPS growth guidance; stock likely offers attractive dividend yield (not disclosed but historically high); potential for further capital returns

  • Mondelez↓ (OPPORTUNITY)
    ◆

    Acquisition of Undercover Snacks adds to portfolio; organic growth expected at least 2% in 2026; Q3 EPS surge (+78.9%) shows operating leverage potential if costs are controlled

  • Kimberly-Clark↓ (OPPORTUNITY)
    ◆

    Kenvue acquisition expected to close Q4 2026, creating a consumer health giant; synergies and cross-selling opportunities could drive re-rating; debt-funded but manageable

  • Clorox↓ (OPPORTUNITY)
    ◆

    New CEO Fabian Garcia brings Unilever pedigree; potential for strategic refresh, cost cuts, or portfolio changes; $11M sign-on RSU aligns interests; watch for initial guidance on Nov 2, 2026

  • Church & Dwight↓ (OPPORTUNITY)
    ◆

    Addition of Jonathon Nudi to board brings fresh perspective and potential M&A expertise; company known for strong execution and brand portfolio

  • Hormel Foods↓ (OPPORTUNITY)
    ◆

    CEO Ghingo now has clear mandate with no specified term; potential for strategic initiatives and improved performance; watch for FY2026 results and 2027 guidance

  • Sector-wide (OPPORTUNITY)
    ◆

    Consumer staples showing pricing power (Hershey +11 pts, Mondelez +0.3%, Altria pricing/mix) but volume pressure; companies with strong brands and cost controls (Hershey, Mondelez) may outperform as inflation moderates

  • Hershey↓ (OPPORTUNITY)
    ◆

    Nine-month operating cash flow $1,638.8M despite working capital headwind; if receivables normalize, cash flow could inflect higher in Q4

  • Altria↓ (OPPORTUNITY)
    ◆

    Nine-month net earnings up 20.0% to $6,999M, aided by absence of prior-year $873M impairment; underlying operating income growth modest but stable

Sector Themes (6)

  • Volume-Price Divergence
    ◆

    Across the sector, companies are relying on price increases to drive revenue growth while volumes decline or stagnate. Hershey saw volume -10 pts offset by +11 pts pricing; Mondelez North America volume/mix flat with pricing +1.6 pp; Altria domestic cigarette volume -2.9% but revenue +1.0%. This suggests consumer resistance to higher prices, and future growth will require volume recovery or further pricing power, which may be limited.

  • Margin Expansion from Lower Costs
    ◆

    Several companies reported significant gross margin expansion due to lower commodity costs and cost controls. Hershey's gross margin jumped to 46.1% from 32.6%, Mondelez's gross profit surged 50.2% on cost of sales decline, and Altria benefited from lower excise taxes. However, SG&A increases (Mondelez +13.3% YTD, Hershey +15.4% Q3) partially offset these gains, indicating that cost inflation is shifting from COGS to operating expenses.

  • Capital Allocation Prioritizes Shareholder Returns
    ◆

    Companies are returning cash via buybacks and dividends while also funding strategic M&A. Altria expanded its buyback by $1B, Hershey repurchased $439M in stock and paid $859M in dividends, and Kimberly-Clark issued $4.9B in debt for the Kenvue acquisition. This suggests confidence in cash flow generation, but also raises leverage concerns for Kimberly-Clark.

  • Management Changes and Board Refreshment
    ◆

    Clorox appointed a new CEO from Unilever, Hormel's CEO role expanded, and Church & Dwight added a director with deep CPG experience. These changes signal a focus on fresh perspectives and strategic execution, particularly as companies navigate volume challenges and cost pressures.

  • M&A Activity in Consumer Staples
    ◆

    Kimberly-Clark's $4.9B debt-funded acquisition of Kenvue and Mondelez's acquisition of Undercover Snacks indicate ongoing consolidation. Companies are seeking growth through bolt-on acquisitions and transformational deals, which could lead to synergies but also integration risks.

  • Mixed Sentiment Dominates
    ◆

    6 of 11 filings carried a 'mixed' sentiment rating, reflecting the balance of positive earnings surprises and negative volume trends. This suggests investors should expect volatility in earnings and stock performance, with company-specific factors driving outcomes.

Watch List (8)

  • 👁

    Q1 fiscal 2027 results on Nov 2, 2026; first report under outgoing CEO Linda Rendle, but watch for commentary on CEO transition and initial guidance for fiscal 2027 [Date: 2026-11-02]

  • Kenvue acquisition expected to close Q4 2026; monitor exchange offers for Kenvue notes and integration updates; debt levels and synergies will be key [Date: Q4 2026]

  • 👁

    Q4 2026 volume trends and working capital management; accounts receivable spike (+52.6%) needs to reverse; watch for 2027 guidance and volume recovery [Date: Early 2027]

  • Integration of Undercover Snacks and performance in Europe; YTD adjusted EPS decline of 0.9% needs to reverse; watch for Q4 2026 results and 2027 outlook [Date: Early 2027]

  • 👁

    NJOY ACE return timeline and e-vapor growth; watch for further buyback activity and dividend announcements; Marlboro share stabilization [Date: Ongoing]

  • CEO John Ghingo's strategic priorities; FY2026 results and 2027 guidance; potential for portfolio changes [Date: Early 2027]

  • Jonathon Nudi joins board Jan 1, 2027; watch for any strategic shifts or M&A activity; Q4 2026 results [Date: 2027-01-01]

  • Sector-wide
    👁

    Consumer price sensitivity and volume trends; any signs of volume recovery or further pricing actions; input cost trends and SG&A leverage [Date: Ongoing]

Filing Analyses (11)
HERSHEY CO 8-K mixed materiality 8/10

29-10-2026

Hershey reported Q3 2026 consolidated net sales of $3,275.5 million, up 3.0% (organic, constant currency +0.8%), with reported net income of $580.8 million ($2.88 per diluted share, up 111.8%) and adjusted EPS of $2.64 (up 103.1%). Growth was driven by approximately 11 points of net price realization, while volume declined approximately 10 points on price elasticity and shipment timing, and the company updated its 2026 outlook: net sales growth now ~5%, organic growth ~3%, adjusted EPS growth 36%-38.5% (raised from 32.5%-35%).

  • · Q3 2026 volume declined ~10 points overall and ~14% in International, reflecting elasticity, shipment timing and planned portfolio optimization
  • · Q3 2026 reported gross margin benefited from derivative mark-to-market gains, tariff refunds, and lower commodity costs; adjusted gross margin was 42.7%
  • · Q3 2026 adjusted EPS includes approximately $0.22 from tariff refunds received in Q3 2026; 2026 adjusted EPS guidance also includes $0.03 from Q2 2026
  • · Q3 2026 North America Salty Snacks organic volume/mix was up ~3 points for the nine months and planned private label reductions weighed on sales versus retail takeaway
  • · Hershey's U.S. CMG share declined year over year in the 12-week period ended September 27, 2026 against a prior-year Reese innovation launch
  • · 2026 outlook excludes potential future tariff refunds; projected effective tax rate ~25%, other expense $5M-$10M, and capex ~$450M
  • · Q3 2026 items negatively impacting comparability totaled $63.7M pre-tax ($0.24 per diluted share), including $113.4M of derivative mark-to-market gains offset by acquisition-related and realignment charges
ALTRIA GROUP, INC. 8-K mixed materiality 7/10

29-10-2026

Altria reported Q3 2026 adjusted diluted EPS of $1.52, up 4.8% YoY, and nine-month adjusted diluted EPS of $4.33, up 5.1%. Q3 net revenues rose 1.0% to $6,132 million while domestic cigarette shipment volume fell 2.9%, and Marlboro retail share declined 1.0 share point YoY to 39.5%. The company raised 2026 adjusted EPS guidance to $5.66–$5.74 (4.5%–6.0% growth) and authorized a $1 billion expansion of its share repurchase program.

  • · Marlboro domestic volume declined 6.4% in Q3 while discount brands grew 40.5%, signaling mix shift toward lower-priced products that pressures volume-driven growth.
  • · Adjusted EPS growth of 4.8% in Q3 was partly supported by a share count reduction and higher ABI earnings, not solely operating performance.
  • · NJOY ACE is not expected to return to the U.S. marketplace in 2026, and e-vapor industry growth is moderating.
  • · Q3 2026 net revenues growth of 1.0% trailed revenues net of excise taxes growth of 3.6%, reflecting excise tax dynamics.
  • · Nine-month reported EPS growth of 21.2% is flattered by lapping a 2025 non-cash goodwill impairment; the underlying adjusted growth is 5.1%.
  • · The company's dividend progressive goal targets mid-single-digit annual DPS growth through 2028; current annualized dividend rate is $4.44 per share.
  • · Share repurchase program expansion expires December 31, 2027.
CLOROX CO /DE/ 8-K mixed materiality 8/10

29-10-2026

Clorox announced that its Board appointed Fabian Garcia, current president of Unilever Personal Care, as CEO effective January 5, 2027, succeeding Linda Rendle, who is stepping down for health reasons. Garcia will join the Board at that time, and Matthew Shattock will become independent chair; Rendle will serve in an advisory capacity through April 2, 2027. The company also noted it will report first-quarter fiscal 2027 results on November 2, 2026.

  • · Rendle will step down as CEO and director on Garcia's start date (January 5, 2027) and remain an advisor through April 2, 2027
  • · Shattock, a former Board chair, returns to the role of independent chair
  • · Rendle announced her departure in May 2026 citing health reasons
  • · Garcia previously served as CEO of Revlon and COO for Global Innovation and Growth at Colgate-Palmolive, and currently sits on the Wells Fargo board
CLOROX CO /DE/ DEFA14A neutral materiality 8/10

29-10-2026

Clorox's Board appointed Fabian Garcia, currently Business Group President of Personal Care at Unilever, as CEO and director effective January 5, 2027, succeeding Linda Rendle, who steps down as CEO and Chair and will serve as senior advisor through April 2, 2027. Matthew J. Shattock, the current Lead Independent Director, becomes Independent Chair, with a $225,000 retainer. Garcia's offer letter sets a $100,000 base salary, $2,000,000 target annual bonus, $4,550,000 pro-rated FY2027 long-term incentive, a $9,100,000 annual LTI beginning September 2027, and an $11,000,000 sign-on RSU award to offset forfeited equity from his prior employer.

  • · Garcia's appointment and Rendle's departure are effective January 5, 2027; Rendle's advisory period runs through April 2, 2027
  • · Rendle's transition is treated as a 'Retirement', so her outstanding long-term incentive awards vest on their original terms, and she receives no new equity awards during the advisory period
  • · Garcia will not receive additional compensation for his board service
  • · The Offer Letter (dated October 27, 2026) and Advisory Agreement will be filed with the Form 10-Q for the quarter ending December 31, 2026
  • · Garcia has no familial relationships or related-party transactions requiring disclosure under Items 401(d) or 404(a) of Regulation S-K
ALTRIA GROUP, INC. 10-Q mixed materiality 7/10

29-10-2026

Altria Group reported Q3 2026 net revenues of $6,132 Million, up 1.0% YoY from $6,072 Million, and net earnings attributable to Altria of $2,518 Million, up 6.0% YoY, with diluted EPS of $1.51 versus $1.41. For the nine months ended September 30, 2026, net revenues rose 1.4% to $17,671 Million and net earnings attributable to Altria increased 20.0% to $6,999 Million, though operating income growth was supported in part by the absence of the prior-year $873 Million goodwill impairment. Stockholders' equity remained in deficit at $(2,173) Million, improving from $(3,452) Million at December 31, 2025.

  • · Cash and cash equivalents fell about 39.7% from $4,474 Million to $2,697 Million, while other current assets rose from $125 Million to $675 Million.
  • · Excise taxes on products declined 10.8% for nine months (to $2,116 Million) and 15.8% for the quarter, which lifted gross profit despite higher cost of sales (up 6.6% for nine months).
  • · Operating income growth for the nine months was not driven by the Q3 quarter alone: Q3 operating income rose only 2.6%, with the bulk of the nine-month gain tied to the non-recurrence of the $873 Million 2025 goodwill impairment.
  • · Long-term debt declined to $22,886 Million from $24,140 Million and current portion fell to $1,175 Million from $1,569 Million.
  • · Investments in equity securities rose to $9,326 Million from $8,617 Million, and income from equity securities increased to $487 Million for nine months.
  • · Dividends declared totaled $3.23 per share for nine months 2026 versus $3.10 in 2025, and dividends payable rose to $1,857 Million.
  • · Settlement charges accrued liabilities declined to $1,942 Million from $2,178 Million, and other accrued liabilities fell to $1,558 Million from $1,947 Million.
Mondelez International, Inc. 10-Q mixed materiality 8/10

29-10-2026

Mondelez reported Q3 2026 net revenues of $9,967M, up 2.3% YoY from $9,744M, while net earnings attributable to the company jumped 75.6% to $1,305M and diluted EPS rose to $1.02 from $0.57. Gross profit surged 50.2% to $3,924M as cost of sales fell 15.3% to $6,043M, but SG&A expenses rose 12.1% to $2,012M and asset impairments/exit costs climbed to $128M from $41M. Nine-month net revenues grew 4.9% to $29,402M with net earnings up 91.1% to $3,413M, though operating cash flow growth (+23.1% to $2,606M) was tempered by a $529M decline in cash balances and higher receivables usage of $1,212M.

  • · Nine-month 2026 SG&A rose to $5,929M from $5,231M (+13.3% YoY)
  • · Nine-month 2026 asset impairments and exit costs were $194M vs $45M prior year
  • · Q3 2026 benefit plan non-service income was $27M vs a $27M expense in Q3 2025
  • · Nine-month 2026 unrealized gain on derivative contracts was $1,091M vs a $1,161M loss prior year
  • · Receivables used $1,212M of cash in 9M 2026 vs $92M in 9M 2025
  • · Nine-month 2026 common stock repurchases fell to $845M from $1,893M
  • · Quarterly dividend raised to $0.520 per share from $0.500
  • · Total debt rose with short-term borrowings at $3,653M vs $2,688M at year-end 2025
  • · Goodwill declined to $24,025M from $24,336M and intangibles to $19,346M from $19,628M
  • · Nine-month 2026 net cash used in financing activities was $1,952M vs $1,346M
CHURCH & DWIGHT CO INC /DE/ 8-K neutral materiality 3/10

29-10-2026

Church & Dwight Co., Inc. elected Jonathon J. Nudi as an independent director effective January 1, 2027, expanding the Board from 11 to 12 members. Nudi, currently President and CEO of Masco Corporation since July 2025, will also join the Audit Committee and Compensation & Human Capital Committee. No related-party transactions or special arrangements were disclosed, and he will receive standard non-employee director compensation.

  • · Nudi has served on Masco's board of directors since June 2023
  • · Nudi's prior roles at General Mills included Group President, Pet, International and North America Foodservice, and earlier Group President, North America Retail
  • · Nudi's election is effective January 1, 2027, with committee appointments taking effect when he joins
  • · No arrangements or understandings between Nudi and any other persons regarding his selection
  • · No related party transactions reportable under Item 404(a) of Regulation S-K
  • · Compensation follows the Company's standard non-employee director policies described in its Schedule 14A proxy statements
  • · Company headquarters: 500 Charles Ewing Boulevard, Ewing, New Jersey 08628; common stock ($1 par value) trades on NYSE under CHD
Mondelez International, Inc. 8-K mixed materiality 8/10

29-10-2026

Mondelez reported Q3 2026 net revenues up 2.3% to $9,967 million, with organic growth of 2.1% driven by volume/mix +1.8% and pricing +0.3%. Diluted EPS jumped 78.9% to $1.02 and Adjusted EPS rose 5.5% constant currency to $0.78, but Europe net revenues declined 3.3% (organic -2.1%) and North America grew only 1.1%, while YTD Adjusted Operating Income fell 1.0% and YTD Adjusted EPS declined 0.9%. The company also announced an agreement to acquire Undercover Snacks and reaffirmed 2026 outlook of at least 2% organic revenue growth and flat-to-5% Adjusted EPS growth.

  • · Europe was the only region with declining net revenues in Q3 (-3.3% reported, -2.1% organic) and YTD organic decline of -2.0%
  • · North America Q3 volume/mix was flat (0.0 pp) with growth driven entirely by pricing (+1.6 pp)
  • · Developed Markets Q3 net revenue growth was just 0.5% (organic 0.8%) with pricing down -0.7 pp
  • · YTD 2026 Adjusted Operating Income declined 1.0% reported and 3.7% constant currency; Adjusted EPS fell 0.9% reported and 4.1% constant currency
  • · Q3 reported gross profit margin rose 1260 basis points to 39.4% largely on favorable mark-to-market derivative impacts, not purely operational gains
  • · 2026 outlook: organic net revenue growth of at least 2%, Adjusted EPS growth flat to 5% constant currency, Free Cash Flow ~$3 billion
  • · Currency translation expected to add ~1.5% to 2026 net revenue growth and $0.04 to Adjusted EPS
  • · Outlook excludes any potential tariff changes to USMCA-compliant trade
  • · YTD capital return of $2.8 billion via dividends and share repurchases
HORMEL FOODS CORP /DE/ 8-K neutral materiality 4/10

29-10-2026

Hormel Foods disclosed in an 8-K that CEO John F. Ghingo's prior Employment Agreement, which covered his service as President and was set to expire December 31, 2026, was terminated effective October 26, 2026 via an October 23, 2026 letter agreement as he assumed the additional role of Chief Executive Officer. As a result, Ghingo now serves as President and CEO with no specified term, and the Letter Agreement will be filed as an exhibit to the FY2026 Form 10-K. The filing contains no financial results or performance metrics.

  • · Ghingo Employment Agreement was scheduled to expire December 31, 2026, but terminated early as of October 26, 2026
  • · Ghingo had been party to the Employment Agreement since June 2025, related to his service as President
  • · Ghingo commenced service as President and CEO effective October 26, 2026, while continuing as a Board member
  • · Letter Agreement dated October 23, 2026; 8-K filed October 29, 2026
  • · Copy of the Letter Agreement expected to be filed as an exhibit to the Form 10-K for fiscal year ended October 25, 2026
  • · Hormel is incorporated in Delaware; IRS Employer Identification No. 41-0319970; Commission File No. 1-2402
KIMBERLY CLARK CORP 8-K neutral materiality 8/10

29-10-2026

Kimberly-Clark Corporation priced $4.9B in aggregate principal amount of senior notes across five tranches (2028, 2029, 2031, 2034, 2036 maturities) and entered a Registration Rights Agreement dated October 29, 2026 with J.P. Morgan, Citigroup and Morgan Stanley as representatives of the initial purchasers. The notes fund/support the pending acquisition of Kenvue Inc. via a two-step merger expected to close in Q4 2026, with a Kenvue guarantee triggered if exchange offers are not completed within four business days after the expiration date. The company commits to an SEC-registered exchange offer within 365 days of the merger closing, with Additional Interest penalties for non-compliance.

  • · Merger Agreement with Kenvue dated November 2, 2025; First Merger Sub merges into Kenvue, then Kenvue merges into Second Merger Sub
  • · Exchange Transactions (offer to exchange Kenvue's existing senior notes) commenced September 28, 2026
  • · Notes issued under First Amended and Restated Indenture dated March 1, 1988, as supplemented by eleventh supplemental indenture
  • · Purchase Agreement dated October 19, 2026 among the Company and the Representatives
  • · Additional Interest provisions apply if registration obligations are not met (Section 4)
  • · Exchange Securities carry no restrictive legend and no Additional Interest provisions
  • · Transfer Restricted Securities status ends at earliest of registration effectiveness, exchange, de-listing, or 3.5 years after original issuance
HERSHEY CO 10-Q mixed materiality 8/10

29-10-2026

Hershey reported Q3 2026 net sales of $3,275.5 million, up 2.9% YoY from $3,181.4 million, while operating profit rose 88.2% to $817.7 million and net income more than doubled to $580.8 million from $276.3 million, aided by a sharp decline in cost of sales. However, growth was modest at the top line, SG&A expense rose 15.4% YoY to $692.9 million, and nine-month operating cash flow of $1,638.8 million was partly offset by $439.4 million in share repurchases and $859.2 million in dividends, leaving cash down 26.9% year to date to $676.7 million.

  • · Gross margin expanded to roughly 46.1% in Q3 2026 from 32.6% in Q3 2025, driven by lower cost of sales ($1,764.5M vs. $2,144.1M)
  • · Net income per diluted share (common stock) was $2.88 in Q3 2026 vs. $1.36 in Q3 2025; nine-month diluted EPS was $7.27 vs. $2.77
  • · Accounts receivable rose 52.6% to $1,113.4M from $729.5M at year-end 2025, absorbing $385.7M of operating cash in the nine months
  • · Inventories increased 12.6% to $1,608.8M, consuming $183.2M of operating cash
  • · Short-term debt rose to $436.0M from $218.5M, while current portion of long-term debt fell to $197.8M from $503.3M
  • · Acquisition added $604.5M of other intangibles (including $303.0M indefinite-lived trademarks) and $281.9M of goodwill, with net assets acquired of $810.2M
  • · Contingent consideration adjustments of $43.8M were recognized in operating cash flow and $16.6M of contingent consideration was paid in financing
  • · Income taxes paid rose to $403.9M from $110.6M, a 265% increase YoY

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 11 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: S&P 500 Consumer Staples Sector SEC Filings

🇺🇸 More from United States

View all →